Fidelity Select Biotechnology Portfolio FBIOX

Morningstar Medalist Rating
  • NAV / 1-Day Return$29.88  /  +3.14%
  • Fund Size$6.0B
  • Adjusted Expense Ratio0.620%
  • Net Expense Ratio0.620%
  • Fee Level: DistributionLow
  • Share Class TypeNo Load
  • Morningstar CategoryHealth
  • Equity Style Box (Funds)Mid Growth
  • Minimum Initial Investment$0
  • Investment StatusOpen
  • TTM Yield1.45%
  • Turnover Ratio45%

Morningstar’s Analysis FBIOX

Will FBIOX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Fidelity Select Biotechnology holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FBIOX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings44.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AbbVie Inc

10.40654M
Healthcare

Krystal Biotech Inc

10.30648M
Healthcare

Amgen Inc

6.98439M
Healthcare

Moderna Inc

3.49220M
Healthcare

Insmed Inc

2.41151M
Healthcare

Revolution Medicines Inc Ordinary Shares

2.40151M
Healthcare

argenx SE ADR

2.32146M
Healthcare

Praxis Precision Medicines Inc Ordinary Shares

2.29144M
Healthcare

Ascendis Pharma AS

2.01126M
Healthcare

Natera Inc

1.72108M
Healthcare

Sponsor Center